Sfoglia per RIVISTA
JOURNAL OF THE NEUROLOGICAL SCIENCES
Collezione AOU San Luigi di Orbassano

  

Items : 6

MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study. in Journal of the neurological sciences / J Neurol Sci. 2021 May 15;424:117385. doi: 10.1016/j.jns.2021.117385. Epub 2021 Mar 6.

2021
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
ASL Torino 4

Clerico M; Sormani MP; Capra R; Costantini G; Cavalla P; Sartori A; Frangiamore R; Laroni A; Gandoglia I; Lanzillo R; Petruzzo M; Landi D; Mataluni G; Baroncini D; Mirabella M; Nociti V; Cocco E; Lorefice L; Curti E; Maniscalco GT; Lavorgna L; Abbadessa G; Bonavita S; Lus G; Signoriello E; Signori A; Cordioli C; De Mercanti SF;

Corrigendum to "Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy?" [J. Neurol. Sci. 378 (2017) 233-237]. in Journal of the neurological sciences / J Neurol Sci. 2017 Sep 15;380:19. doi: 10.1016/j.jns.2017.06.037. Epub 2017 Jul 4.

2017
AOU San Luigi di Orbassano
AOU Novara

Gerevini S; Imberti L; Naldi P; Moiola L; Capobianco M; Lugaresi A; De Rossi N; Mancinelli CR; Prosperini L; Scarpazza C; Capra R;

Is maraviroc useful in multiple sclerosis patients with natalizumab-related progressive multifocal leukoencephalopathy? in Journal of the neurological sciences / J Neurol Sci. 2017 Jul 15;378:233-237. doi: 10.1016/j.jns.2017.05.018. Epub 2017 May 12.

2017
AOU San Luigi di Orbassano
AOU Novara

Gerevini S; Imberti L; Naldi P; Moiola L; Capobianco M; Lugaresi A; De Rossi N; Mancinelli CR; Prosperini L; Scarpazza C; Capra R;

Implications of neutralising antibodies on therapeutic efficacy. in Journal of the neurological sciences / J Neurol Sci. 2009 Feb 1;277 Suppl 1:S29-32. doi: 10.1016/S0022-510X(09)70009-7.

2009
AOU San Luigi di Orbassano

Bertolotto A;

High incidence of acute leukaemia in multiple sclerosis patients treated with mitoxantrone: A retrospective multicentre Italian study in Journal of the Neurological Sciences

2009
AOU San Luigi di Orbassano

Martinelli V; Capra R; Gasperini C; Cocco E; Bellantonio P; Pesci I; Bertolotto A; Gallo P; Amato MP; Ghezzis A; Grimaldi L; Lugaresi A; Mancardi G; Bergamaschi R; Ponzio M; Pozzilli C; Salemi G; Trojano M; Rodegher ME; Straffi L; Comi G;

High-dose, frequently administered interferon beta therapy for relapsing-remitting multiple sclerosis must be maintained over the long term: the interferon beta dose-reduction study. in Journal of the neurological sciences / J Neurol Sci. 2004 Jul 15;222(1-2):13-9. doi: 10.1016/j.jns.2004.03.023.

2004
AOU San Luigi di Orbassano

Barbero P; Verdun E; Bergui M; Pipieri A; Clerico M; Cucci A; Ricci A; Bergamasco B; Durelli L;